Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) Director William Bradley purchased 16,129 shares of Fractyl Health stock in a transaction dated Thursday, March 13th. The shares were bought at an average cost of $1.26 per share, for a total transaction of $20,322.54. Following the transaction, the director now directly owns 16,129 shares of the company's stock, valued at approximately $20,322.54. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Fractyl Health Stock Performance
Shares of GUTS stock opened at $1.27 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.57 and a current ratio of 5.58. The company's 50-day simple moving average is $1.64 and its 200-day simple moving average is $2.16. Fractyl Health, Inc. has a one year low of $1.16 and a one year high of $8.37. The stock has a market capitalization of $62.13 million and a price-to-earnings ratio of -0.10.
Fractyl Health (NASDAQ:GUTS - Get Free Report) last issued its earnings results on Monday, March 3rd. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.44) by ($0.08). Equities analysts anticipate that Fractyl Health, Inc. will post -1.61 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Separately, Morgan Stanley reduced their price target on shares of Fractyl Health from $18.00 to $10.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd.
Check Out Our Latest Analysis on GUTS
Hedge Funds Weigh In On Fractyl Health
A number of large investors have recently bought and sold shares of the business. Massachusetts Financial Services Co. MA lifted its holdings in Fractyl Health by 4.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,045,672 shares of the company's stock worth $2,646,000 after acquiring an additional 49,289 shares during the last quarter. 683 Capital Management LLC lifted its holdings in Fractyl Health by 4.0% in the fourth quarter. 683 Capital Management LLC now owns 650,000 shares of the company's stock worth $1,339,000 after acquiring an additional 25,000 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Fractyl Health by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 513,079 shares of the company's stock valued at $1,057,000 after buying an additional 11,603 shares during the last quarter. Silverarc Capital Management LLC raised its holdings in shares of Fractyl Health by 6.2% during the fourth quarter. Silverarc Capital Management LLC now owns 176,922 shares of the company's stock valued at $364,000 after buying an additional 10,256 shares during the last quarter. Finally, State Street Corp raised its holdings in shares of Fractyl Health by 129.4% during the third quarter. State Street Corp now owns 113,415 shares of the company's stock valued at $287,000 after buying an additional 63,968 shares during the last quarter.
About Fractyl Health
(
Get Free Report)
Fractyl Health, Inc, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
